KYMR

$0.00

(

+0.00%

)
Quote details

stock

Kymera Therapeutics Inc

NASDAQ | KYMR

89.68

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 12, 2025)

$7.02B

Market Cap

-

P/E Ratio

-3.51

EPS

$103.00

52 Week High

$19.45

52 Week Low

HEALTHCARE

Sector

KYMR Chart

Recent Chart
Price Action

KYMR Technicals

Tags:

KYMR Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $47M
Total Revenue $47M
Cost Of Revenue $7.4M
Costof Goods And Services Sold $7.4M
Operating Income -$262M
Selling General And Administrative $64M
Research And Development $240M
Operating Expenses $309M
Investment Income Net -
Net Interest Income $38M
Interest Income $38M
Interest Expense $249K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $7.4M
Income Before Tax -$224M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$224M
Comprehensive Income Net Of Tax -
Ebit -$224M
Ebitda -$216M
Net Income -$224M

Revenue & Profitability

KYMR Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $978M
Total Current Assets $510M
Cash And Cash Equivalents At Carrying Value $120M
Cash And Short Term Investments $120M
Inventory -
Current Net Receivables $947K
Total Non Current Assets $468M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $362M
Short Term Investments $368M
Other Current Assets $21M
Other Non Current Assets -
Total Liabilities $142M
Total Current Liabilities $68M
Current Accounts Payable $6M
Deferred Revenue -
Current Debt -
Short Term Debt $13M
Total Non Current Liabilities $75M
Capital Lease Obligations $88M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $88M
Other Current Liabilities $35M
Other Non Current Liabilities -
Total Shareholder Equity $836M
Treasury Stock -
Retained Earnings -$755M
Common Stock $7K
Common Stock Shares Outstanding $75M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $47M
Total Revenue $47M
Cost Of Revenue $7.4M
Costof Goods And Services Sold $7.4M
Operating Income -$262M
Selling General And Administrative $64M
Research And Development $240M
Operating Expenses $309M
Investment Income Net -
Net Interest Income $38M
Interest Income $38M
Interest Expense $249K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $7.4M
Income Before Tax -$224M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$224M
Comprehensive Income Net Of Tax -
Ebit -$224M
Ebitda -$216M
Net Income -$224M

KYMR Profile

Kymera Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Kymera Therapeutics Inc. is an innovative biopharmaceutical company headquartered in Watertown, Massachusetts, focused on transforming treatment paradigms through its proprietary protein degradation technology. By leveraging the body's inherent protein regulation systems, Kymera develops targeted small molecule therapies designed to selectively degrade disease-causing proteins related to cancer and autoimmune disorders. This unique therapeutic approach positions the company favorably within the biopharmaceutical sector, offering substantial growth potential for institutional investors as it progresses its robust pipeline toward clinical applications.

LPTX
+368.57%
$2.05
PAVS
+13.62%
$0.03
YCBD
+76.59%
$1.11
OCG
-59.39%
$0.36
NVDA
-2.82%
$175.81
CGC
+54.86%
$1.75
YGMZ
-61.42%
$0.02
PLUG
+0.42%
$2.37
WOK
-31.78%
$0.11
RIVN
+12.75%
$18.52
ASST
-5.06%
$0.87
TSLA
+1.82%
$455.03
AVGO
-12.32%
$356.27
ONDS
+2.39%
$9.23
ATPC
-24.77%
$0.13
KIND
+9.48%
$2.77
TLRY
+43.89%
$12.13
AXDX
-61.36%
$0.03
INTC
-4.39%
$37.77
AKAN
+9.38%
$0.86
KAVL
-35.55%
$0.12
FRMI
-30.53%
$10.59
TNYA
-35.26%
$0.88
ADAP
-15.14%
$0.05
ZDGE
+18.51%
$2.88
TE
-9.70%
$5.30
VIVK
-3.78%
$0.07
ORCL
-4.61%
$189.67
PLTD
+2.84%
$6.50
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
BMNR
-8.59%
$35.08
SOFI
+0.72%
$27.26
LNW
-3.71%
$86.22
WULF
-6.66%
$14.77
ADD
-25.47%
$0.05
DNN
-5.06%
$2.62
AAL
+0.90%
$15.09
MARA
-1.31%
$11.68
PLTR
-2.21%
$183.39
F
+0.69%
$13.72
BMNU
-15.75%
$8.61
RR
-9.54%
$4.23
SRM
+53.27%
$10.30
APLT
-45.78%
$0.11
PFE
-0.01%
$25.79
BYND
-5.93%
$1.11
ACHR
-1.10%
$8.46
IRBT
-12.69%
$4.36
NFLX
+1.72%
$95.71
CLSK
-3.10%
$14.36
KVUE
+0.13%
$17.34
ASBP
-5.64%
$0.09
IREN
-6.88%
$40.91
CRWV
-8.43%
$80.00
BITF
-4.59%
$2.80
MTSR
-0.35%
$70.50
AMD
-4.41%
$211.65
RKLB
-0.92%
$62.94
NIO
-2.04%
$5.02
CIFR
-7.83%
$17.40
FI
+2.38%
$68.16
WBD
+1.33%
$29.88
HOOD
-2.39%
$120.42
BBD
+0.73%
$3.43
QBTS
-2.99%
$27.14
SNAP
-2.66%
$7.43
GOOGL
-0.80%
$309.92
BAC
+1.06%
$55.14
VALE
-4.55%
$12.68
CAN
-8.01%
$0.85
SOUN
-2.82%
$11.69
AAPL
+0.05%
$278.17
BTG
-1.07%
$4.62
CHR
-1.21%
$0.04
AFMD
-34.94%
$0.18
T
+0.89%
$24.51
IVP
-9.22%
$0.04
AMZN
-1.41%
$227.01
ABEV
+1.79%
$2.54
GRAB
+1.05%
$5.23
AG
-5.68%
$15.85
RZLT
+9.32%
$1.53
SMR
-10.50%
$18.99
TWOH
0.00%
$0.00
KPLT
+17.64%
$7.30
BTBT
-7.01%
$2.28
NOK
-1.48%
$6.26
GRYP
-10.38%
$1.38
HPE
-2.50%
$23.92
MODV
-25.22%
$0.43
CDE
-1.40%
$17.23
RIG
-2.10%
$4.19
DVLT
0.00%
$1.44
CMG
+3.87%
$36.22
GPUS
-4.78%
$0.27
BLNK
-11.77%
$0.78
MU
-4.48%
$246.88
APLD
-2.08%
$30.12
HL
-3.85%
$18.60
LPTX
+368.57%
$2.05
PAVS
+13.62%
$0.03
YCBD
+76.59%
$1.11
OCG
-59.39%
$0.36
NVDA
-2.82%
$175.81
CGC
+54.86%
$1.75
YGMZ
-61.42%
$0.02
PLUG
+0.42%
$2.37
WOK
-31.78%
$0.11
RIVN
+12.75%
$18.52
ASST
-5.06%
$0.87
TSLA
+1.82%
$455.03
AVGO
-12.32%
$356.27
ONDS
+2.39%
$9.23
ATPC
-24.77%
$0.13
KIND
+9.48%
$2.77
TLRY
+43.89%
$12.13
AXDX
-61.36%
$0.03
INTC
-4.39%
$37.77
AKAN
+9.38%
$0.86
KAVL
-35.55%
$0.12
FRMI
-30.53%
$10.59
TNYA
-35.26%
$0.88
ADAP
-15.14%
$0.05
ZDGE
+18.51%
$2.88
TE
-9.70%
$5.30
VIVK
-3.78%
$0.07
ORCL
-4.61%
$189.67
PLTD
+2.84%
$6.50
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
BMNR
-8.59%
$35.08
SOFI
+0.72%
$27.26
LNW
-3.71%
$86.22
WULF
-6.66%
$14.77
ADD
-25.47%
$0.05
DNN
-5.06%
$2.62
AAL
+0.90%
$15.09
MARA
-1.31%
$11.68
PLTR
-2.21%
$183.39
F
+0.69%
$13.72
BMNU
-15.75%
$8.61
RR
-9.54%
$4.23
SRM
+53.27%
$10.30
APLT
-45.78%
$0.11
PFE
-0.01%
$25.79
BYND
-5.93%
$1.11
ACHR
-1.10%
$8.46
IRBT
-12.69%
$4.36
NFLX
+1.72%
$95.71
CLSK
-3.10%
$14.36
KVUE
+0.13%
$17.34
ASBP
-5.64%
$0.09
IREN
-6.88%
$40.91
CRWV
-8.43%
$80.00
BITF
-4.59%
$2.80
MTSR
-0.35%
$70.50
AMD
-4.41%
$211.65
RKLB
-0.92%
$62.94
NIO
-2.04%
$5.02
CIFR
-7.83%
$17.40
FI
+2.38%
$68.16
WBD
+1.33%
$29.88
HOOD
-2.39%
$120.42
BBD
+0.73%
$3.43
QBTS
-2.99%
$27.14
SNAP
-2.66%
$7.43
GOOGL
-0.80%
$309.92
BAC
+1.06%
$55.14
VALE
-4.55%
$12.68
CAN
-8.01%
$0.85
SOUN
-2.82%
$11.69
AAPL
+0.05%
$278.17
BTG
-1.07%
$4.62
CHR
-1.21%
$0.04
AFMD
-34.94%
$0.18
T
+0.89%
$24.51
IVP
-9.22%
$0.04
AMZN
-1.41%
$227.01
ABEV
+1.79%
$2.54
GRAB
+1.05%
$5.23
AG
-5.68%
$15.85
RZLT
+9.32%
$1.53
SMR
-10.50%
$18.99
TWOH
0.00%
$0.00
KPLT
+17.64%
$7.30
BTBT
-7.01%
$2.28
NOK
-1.48%
$6.26
GRYP
-10.38%
$1.38
HPE
-2.50%
$23.92
MODV
-25.22%
$0.43
CDE
-1.40%
$17.23
RIG
-2.10%
$4.19
DVLT
0.00%
$1.44
CMG
+3.87%
$36.22
GPUS
-4.78%
$0.27
BLNK
-11.77%
$0.78
MU
-4.48%
$246.88
APLD
-2.08%
$30.12
HL
-3.85%
$18.60

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.